デフォルト表紙
市場調査レポート
商品コード
1585115

次世代遠心分離機の世界市場:産業分析、規模、シェア、成長、動向、予測(2024年~2031年)

Next Generation Centrifuge Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031


出版日
ページ情報
英文 123 Pages
納期
2~5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
次世代遠心分離機の世界市場:産業分析、規模、シェア、成長、動向、予測(2024年~2031年)
出版日: 2024年11月07日
発行: Persistence Market Research
ページ情報: 英文 123 Pages
納期: 2~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の次世代遠心分離機市場について調査分析し、市場の促進要因、動向、機会、促進要因、課題などの重要な市場力学の評価や、市場構造に関する詳細な見識を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場のイントロダクション

第3章 世界の次世代遠心分離機分析シナリオ

  • 市場数量の分析
    • 稼働台数:地域別
  • 市場の概要
    • バリューチェーン

第4章 市場力学

  • マクロ経済要因
  • 促進要因
    • サプライサイド
    • デマンドサイド
  • 抑制要因
  • 機会
  • 予測要因 - 関連性と影響
  • 製品比較マトリクス
  • ローターを構成する材料の概要

第5章 世界の次世代遠心分離機の分析と予測:製品別

  • イントロダクション
  • ベーシスポイントシェア(BPS)分析:製品タイプ別
  • 前年比成長予測:製品タイプ別
  • 市場の金額と数量の予測:製品別
    • 冷却遠心分離機
    • 常温遠心分離機
  • 注目すべき動向
  • 市場の魅力:製品別

第6章 世界の次世代遠心分離機の分析と予測:エンドユーザー別

  • イントロダクション
  • ベーシスポイントシェア(BPS)分析:エンドユーザー別
  • 前年比成長予測:エンドユーザー別
  • 市場の金額と数量の予測:エンドユーザー別
    • 病院
    • 学術研究機関
    • バイオ医薬品企業
    • 開発業務受託機関
    • 診断センター
  • 注目すべき動向
  • 市場の魅力:エンドユーザー別

第7章 世界の次世代遠心分離機の分析と予測:地域別

  • ベーシスポイントシェア(BPS)分析:地域別
  • 前年比成長予測:地域別
  • 市場の金額と数量の予測:地域別
    • 北米
    • ラテンアメリカ
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
  • 市場の魅力:地域別

第8章 北米の次世代遠心分離機の分析と予測

  • イントロダクション
    • ベーシスポイントシェア(BPS)分析:国別
    • 前年比成長予測:国別
  • 市場の金額と数量の予測:製品別
    • 冷却遠心分離機
    • 常温遠心分離機
  • 市場の金額と数量の予測:エンドユーザー別
    • 病院
    • 学術研究機関
    • バイオ医薬品企業
    • 開発業務受託機関
    • 診断センター
  • 市場の金額と数量の予測:国別
    • 米国
    • カナダ
  • 市場の魅力分析
    • 製品別
    • エンドユーザー別
    • 国別
  • 促進要因と抑制要因:影響の分析

第9章 ラテンアメリカの次世代遠心分離機の分析と予測

  • イントロダクション
    • ベーシスポイントシェア(BPS)分析:国別
    • 前年比成長予測:国別
  • 市場の金額と数量の予測:製品別
    • 冷却遠心分離機
    • 常温遠心分離機
  • 市場の金額と数量の予測:エンドユーザー別
    • 病院
    • 学術研究機関
    • バイオ医薬品企業
    • 開発業務受託機関
    • 診断センター
  • 市場の金額と数量の予測:国別
    • ブラジル
    • メキシコ
    • その他のラテンアメリカ
  • 市場の魅力分析
    • 製品別
    • エンドユーザー別
    • 国別
  • 促進要因と抑制要因:影響の分析

第10章 欧州の次世代遠心分離機の分析と予測

  • イントロダクション
    • ベーシスポイントシェア(BPS)分析:国別
    • 前年比成長予測:国別
  • 市場の金額と数量の予測:製品別
    • 冷却遠心分離機
    • 常温遠心分離機
  • 市場の金額と数量の予測:エンドユーザー別
    • 病院
    • 学術研究機関
    • バイオ医薬品企業
    • 開発業務受託機関
    • 診断センター
  • 市場の金額と数量の予測:国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • ロシア
    • その他の欧州
  • 市場の魅力分析
    • 製品別
    • エンドユーザー別
    • 国別
  • 促進要因と抑制要因:影響の分析

第11章 アジア太平洋の次世代遠心分離機の分析と予測

  • イントロダクション
    • ベーシスポイントシェア(BPS)分析:国別
    • 前年比成長予測:国別
  • 市場の金額と数量の予測:製品別
    • 冷却遠心分離機
    • 常温遠心分離機
  • 市場の金額と数量の予測:エンドユーザー別
    • 病院
    • 学術研究機関
    • バイオ医薬品企業
    • 開発業務受託機関
    • 診断センター
  • 市場の金額と数量の予測:国別
    • 日本
    • 中国
    • インド
    • オーストラリア・ニュージーランド
    • ASEAN
    • その他のアジア太平洋
  • 市場の魅力分析
    • 製品別
    • エンドユーザー別
    • 国別
  • 促進要因と抑制要因:影響の分析

第12章 中東・アフリカの次世代遠心分離機の分析と予測

  • イントロダクション
    • ベーシスポイントシェア(BPS)分析:国別
    • 前年比成長予測:国別
  • 市場の金額と数量の予測:製品別
    • 冷却遠心分離機
    • 常温遠心分離機
  • 市場の金額と数量の予測:エンドユーザー別
    • 病院
    • 学術研究機関
    • バイオ医薬品企業
    • 開発業務受託機関
    • 診断センター
  • 市場の金額と数量の予測:国別
    • GCC諸国
    • 南アフリカ
    • 北アフリカ
    • その他の中東・アフリカ
  • 市場の魅力分析
    • 製品別
    • エンドユーザー別
    • 国別
  • 促進要因と抑制要因:影響の分析

第13章 競合情勢

  • 競合ダッシュボード
  • 市場シェア分析:企業別(2024年)
  • 企業プロファイル(詳細 - 概要、財務、戦略、近年の動向)
    • Eppendorf
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation (Beckman Coulter)
    • NuAire Inc.
    • Corning Inc.
    • Hettich GmbH & Co.KG
    • Qiagen
    • Hitachi Koki Co., Ltd

第14章 使用される前提条件と頭字語

第15章 調査手法

目次
Product Code: PMRREP11644

Persistence Market Research has recently released a comprehensive report on the global Next Generation Centrifuge market. This report provides an in-depth evaluation of critical market dynamics, including drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

  • Next Generation Centrifuge Market Size (2024E): USD 1415.9 Mn
  • Projected Market Value (2031F): USD 2129 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.00%

Next Generation Centrifuge Market - Report Scope:

Next Generation Centrifuges represent an advanced category of centrifugation devices, primarily used in scientific research, clinical diagnostics, and industrial applications for the separation of substances based on density. These devices are distinguished by innovations in automation, accuracy, and ease of use, catering to laboratories, research institutions, and production facilities. Market growth is driven by advancements in biomedical research, the rise of personalized medicine, and increasing investments in pharmaceutical and biotechnological research.

Market Growth Drivers:

The global Next Generation Centrifuge market is propelled by several key factors, including the rapid expansion of the biotechnology and pharmaceutical sectors. The development of personalized medicine and biologics has driven demand for more precise and efficient separation technologies, positioning Next Generation Centrifuges as essential tools in research and diagnostics. Additionally, technological innovations, such as digital monitoring, remote control, and automated operations, improve the usability and efficiency of these centrifuges, promoting adoption across various sectors. Rising healthcare spending and increasing R&D investments in life sciences also stimulate market expansion.

Market Restraints:

Despite the promising growth prospects, the Next Generation Centrifuge market faces challenges related to high acquisition and maintenance costs. The advanced technologies integrated into these devices, such as digital interfaces and high-speed motors, often come with substantial costs that may limit adoption in smaller laboratories and facilities. Additionally, a lack of skilled professionals to operate these sophisticated centrifuges presents a challenge, particularly in developing regions. Addressing these issues will require ongoing education and training efforts, as well as cost reduction strategies by manufacturers.

Market Opportunities:

The Next Generation Centrifuge market presents significant opportunities driven by increasing research activities in genomics and proteomics and expanding applications across industries. The development of portable, compact centrifuges opens new markets in field research and point-of-care testing. Further, the rising adoption of centrifugation techniques in agriculture, food processing, and wastewater treatment sectors presents new revenue streams. Strategic collaborations with research institutions, investment in sustainable manufacturing, and introduction of cost-effective models are essential for capitalizing on emerging opportunities and establishing market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Next Generation Centrifuge market globally?
  • Which application areas are leading the adoption of Next Generation Centrifuge technologies?
  • How are technological advancements influencing the competitive landscape of the Next Generation Centrifuge market?
  • Who are the key players in the Next Generation Centrifuge market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Next Generation Centrifuge market?

Competitive Intelligence and Business Strategy:

Leading players in the global Next Generation Centrifuge market, including Thermo Fisher Scientific, Eppendorf AG, and Beckman Coulter, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest heavily in R&D to develop advanced centrifuge models with digital monitoring capabilities and enhanced safety features. Collaborations with research institutions, hospitals, and universities promote product adoption and foster new product development. Emphasis on energy efficiency, sustainability, and effective marketing strategies enhances brand reputation and widens the consumer base for Next Generation Centrifuges.

Key Companies Profiled:

  • Eppendorf
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation (Beckman Coulter)
  • Polypipe (Nuaire)
  • Corning Inc.
  • Hettich GmbH & Co.KG
  • Qiagen
  • Hitachi Koki Co., Ltd
  • Others

Next Generation Centrifuge Industry Segmentation:

By Product Type

  • Refrigerated Centrifuge
  • Ambient Centrifuge

By End Users

  • Hospitals
  • Academic and Research Organizations
  • Biopharmaceuticals Companies
  • Contract Research Organizations
  • Diagnostic Centers

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Executive Summary

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Global Next Generation Centrifuge Analysis Scenario

  • 3.1. Market Volume Analysis
    • 3.1.1. Installed Base By Region
  • 3.2. Market Overview
    • 3.2.1. Value Chain

4. Market Dynamics

  • 4.1. Macro-economic Factors
  • 4.2. Drivers
    • 4.2.1. Supply Side
    • 4.2.2. Demand Side
  • 4.3. Restraints
  • 4.4. Opportunity
  • 4.5. Forecast Factors - Relevance and Impact
  • 4.6. Product Comparison Matrix
  • 4.7. Overview of Materials for Rotor Construction

5. Global Next Generation Centrifuge Analysis and Forecasts, By Product

  • 5.1. Introduction
  • 5.2. Basis Point Share (BPS) Analysis By Product Type
  • 5.3. Y-o-Y Growth Projections By Product Type
  • 5.4. Market Value and Volume Forecast By Product, 2024-2031
    • 5.4.1. Refrigerated Centrifuges
      • 5.4.1.1. Refrigerated Benchtop
      • 5.4.1.2. Refrigerated Floor standing
    • 5.4.2. Ambient Centrifuges
      • 5.4.2.1. Ambient Benchtop
      • 5.4.2.2. Ambient Floor standing
  • 5.5. Prominent Trends
  • 5.6. Market Attractiveness By Product

6. Global Next Generation Centrifuge Analysis and Forecasts, By End User

  • 6.1. Introduction
  • 6.2. Basis Point Share (BPS) Analysis By End User
  • 6.3. Y-o-Y Growth Projections By End User
  • 6.4. Market Value and Volume Forecast By End User, 2024-2031
    • 6.4.1. Hospitals
    • 6.4.2. Academic and Research Institutes
    • 6.4.3. Biopharmaceuticals companies
    • 6.4.4. Contract research Organization
    • 6.4.5. Diagnostic Centers
  • 6.5. Prominent Trends
  • 6.6. Market Attractiveness By End User

7. Global Next Generation Centrifuge Analysis and Forecasts, By Region

  • 7.1. Basis Point Share (BPS) Analysis By Region
  • 7.2. Y-o-Y Growth Projections By Region
  • 7.3. Market Value and Volume Forecast By Region
    • 7.3.1. North America
    • 7.3.2. Latin America
    • 7.3.3. Europe
    • 7.3.4. APEJ
    • 7.3.5. MEA
  • 7.4. Market Attractiveness By Region

8. North America Next Generation Centrifuge Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Basis Point Share (BPS) Analysis By Country
    • 8.1.2. Y-o-Y Growth Projections By Country
  • 8.2. Market Value and Volume Forecast By Product, 2024-2031
    • 8.2.1. Refrigerated Centrifuges
      • 8.2.1.1. Refrigerated Benchtop
      • 8.2.1.2. Refrigerated Floor standing
    • 8.2.2. Ambient Centrifuges
      • 8.2.2.1. Ambient Benchtop
      • 8.2.2.2. Ambient Floor standing
  • 8.3. Market Value and Volume Forecast By End User, 2024-2031
    • 8.3.1. Hospitals
    • 8.3.2. Academic and Research Institutes
    • 8.3.3. Biopharmaceuticals companies
    • 8.3.4. Contract research Organization
    • 8.3.5. Diagnostic Centers
  • 8.4. Market Value and Volume Forecast By Country, 2024-2031
    • 8.4.1. US
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Product
    • 8.5.2. By End User
    • 8.5.3. By Country
  • 8.6. Drivers and Restraints: Impact Analysis

9. Latin America Next Generation Centrifuge Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Basis Point Share (BPS) Analysis By Country
    • 9.1.2. Y-o-Y Growth Projections By Country
  • 9.2. Market Value and Volume Forecast By Product, 2024-2031
    • 9.2.1. Refrigerated Centrifuges
      • 9.2.1.1. Refrigerated Benchtop
      • 9.2.1.2. Refrigerated Floor standing
    • 9.2.2. Ambient Centrifuges
      • 9.2.2.1. Ambient Benchtop
      • 9.2.2.2. Ambient Floor standing
  • 9.3. Market Value and Volume Forecast By End User, 2024-2031
    • 9.3.1. Hospitals
    • 9.3.2. Academic and Research Institutes
    • 9.3.3. Biopharmaceuticals companies
    • 9.3.4. Contract research Organization
    • 9.3.5. Diagnostic Centers
  • 9.4. Market Value and Volume Forecast By Country, 2024-2031
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By End User
    • 9.5.3. By Country
  • 9.6. Drivers and Restraints: Impact Analysis

10. Europe Next Generation Centrifuge Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Basis Point Share (BPS) Analysis By Country
    • 10.1.2. Y-o-Y Growth Projections By Country
  • 10.2. Market Value and Volume Forecast By Product, 2024-2031
    • 10.2.1. Refrigerated Centrifuges
      • 10.2.1.1. Refrigerated Benchtop
      • 10.2.1.2. Refrigerated Floor standing
    • 10.2.2. Ambient Centrifuges
      • 10.2.2.1. Ambient Benchtop
      • 10.2.2.2. Ambient Floor standing
  • 10.3. Market Value and Volume Forecast By End User, 2024-2031
    • 10.3.1. Hospitals
    • 10.3.2. Academic and Research Institutes
    • 10.3.3. Biopharmaceuticals companies
    • 10.3.4. Contract research Organization
    • 10.3.5. Diagnostic Centers
  • 10.4. Market Value and Volume Forecast By Country, 2024-2031
    • 10.4.1. UK
    • 10.4.2. France
    • 10.4.3. Germany
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Russia
    • 10.4.7. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By End User
    • 10.5.3. By Country
  • 10.6. Drivers and Restraints: Impact Analysis

11. APAC Next Generation Centrifuge Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Basis Point Share (BPS) Analysis By Country
    • 11.1.2. Y-o-Y Growth Projections By Country
  • 11.2. Market Value and Volume Forecast By Product, 2024-2031
    • 11.2.1. Refrigerated Centrifuges
      • 11.2.1.1. Refrigerated Benchtop
      • 11.2.1.2. Refrigerated Floor standing
    • 11.2.2. Ambient Centrifuges
      • 11.2.2.1. Ambient Benchtop
      • 11.2.2.2. Ambient Floor standing
  • 11.3. Market Value and Volume Forecast By End User, 2024-2031
    • 11.3.1. Hospitals
    • 11.3.2. Academic and Research Institutes
    • 11.3.3. Biopharmaceuticals companies
    • 11.3.4. Contract research Organization
    • 11.3.5. Diagnostic Centers
  • 11.4. Market Value and Volume Forecast By Country, 2024-2031
    • 11.4.1. Japan
    • 11.4.2. China
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. ASEAN
    • 11.4.6. Rest of APAC
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By End User
    • 11.5.3. By Country
  • 11.6. Drivers and Restraints: Impact Analysis

12. MEA Next Generation Centrifuge Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Basis Point Share (BPS) Analysis By Country
    • 12.1.2. Y-o-Y Growth Projections By Country
  • 12.2. Market Value and Volume Forecast By Product, 2024-2031
    • 12.2.1. Refrigerated Centrifuges
      • 12.2.1.1. Refrigerated Benchtop
      • 12.2.1.2. Refrigerated Floor standing
    • 12.2.2. Ambient Centrifuges
      • 12.2.2.1. Ambient Benchtop
      • 12.2.2.2. Ambient Floor standing
  • 12.3. Market Value and Volume Forecast By End User, 2024-2031
    • 12.3.1. Hospitals
    • 12.3.2. Academic and Research Institutes
    • 12.3.3. Biopharmaceuticals companies
    • 12.3.4. Contract research Organization
    • 12.3.5. Diagnostic Centers
  • 12.4. Market Value and Volume Forecast By Country, 2024-2031
    • 12.4.1. GCC Countries
    • 12.4.2. South Africa
    • 12.4.3. North Africa
    • 12.4.4. Rest of MEA
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By End User
    • 12.5.3. By Country
  • 12.6. Drivers and Restraints: Impact Analysis

13. Competition Landscape

  • 13.1. Competition Dashboard
  • 13.2. Market Share Analysis By Company (2024)
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Eppendorf
    • 13.3.2. Thermo Fisher Scientific Inc.
    • 13.3.3. Danaher Corporation (Beckman Coulter)
    • 13.3.4. NuAire Inc.
    • 13.3.5. Corning Inc.
    • 13.3.6. Hettich GmbH & Co.KG
    • 13.3.7. Qiagen
    • 13.3.8. Hitachi Koki Co., Ltd

14. Assumptions and Acronyms Used

15. Research Methodology